COSMOS Pharmaceutical Revenue

COSMOS Pharmaceutical had revenue of 246.33B JPY in the quarter ending February 28, 2025, with 3.12% growth. This brings the company's revenue in the last twelve months to 1.00T, up 6.96% year-over-year. In the fiscal year ending May 31, 2024, COSMOS Pharmaceutical had annual revenue of 964.99B with 16.59% growth.

Revenue (ttm)

1,001.95B

Revenue Growth

+6.96%

P/S Ratio

0.69

Revenue / Employee

181.78M

Employees

5,512

Market Cap

689.62B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2024	964.99B	137.29B	16.59%
May 31, 2023	827.70B	72.28B	9.57%
May 31, 2022	755.41B	28.99B	3.99%
May 31, 2021	726.42B	42.02B	6.14%
May 31, 2020	684.40B	73.27B	11.99%
May 31, 2019	Pro	Pro	Pro
May 31, 2018	Pro	Pro	Pro
May 31, 2017	Pro	Pro	Pro
May 31, 2016	Pro	Pro	Pro
May 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Takeda Pharmaceutical Company	4,579.02B
Daiichi Sankyo Company	1,795.99B
HOYA Corporation	838.60B
Terumo	1,011.15B
Otsuka Holdings	2,329.86B
Astellas Pharma	1,867.63B
Shionogi &	456.87B

Revenue Rankings